Interactions between two specific subsets of immune cells may contribute to disease activity in people with immunoglobulin G4-related disease (IgG4-RD), according to a new study. Researchers speculated that this newly identified immune-related axis could be a potential target for new IgG4-RD treatments. The study, “Extrafollicular [Tph2–CD11c-positive,…
